| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GT Biopharma, Inc. | Pres. of R&D, CMO | Option to purchase Common Stock | 50,000 | 15 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GTBP | GT Biopharma, Inc. | 15 Jul 2022 | 1 | $0 | 4 | Pres. of R&D, CMO | 19 Jul 2022, 21:44 |
| GTBP | GT Biopharma, Inc. | 16 Feb 2021 | 2 | $0 | 4 | Director | 14 Feb 2022, 16:10 |
| GTBP | GT Biopharma, Inc. | 11 Nov 2020 | 0 | $0 | 3 | Director | 14 Feb 2022, 15:06 |